专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2005005610A2 MUTANT ADENO-ASSOCIATED VIRUS VIRIONS AND METHODS OF USE THEREOF 审中-公开
标题翻译：突变腺病毒相关病毒及其使用方法
公开(公告)号：WO2005005610A2
公开(公告)日：2005-01-20
申请号：PCT/US2004/021121
申请日：2004-06-29
申请人： THE REGENTS OF THE UNIVERSITY OF CALIFORNIA , SCHAFFER, David, V. , KASPAR, Brian , MAHESHRI, Narendra
发明人： SCHAFFER, David, V. , KASPAR, Brian , MAHESHRI, Narendra
IPC分类号： C12N
CPC分类号： C07K14/005 , C12N15/86 , C12N2750/14122 , C12N2750/14143
摘要： The present invention provides mutant adeno-associated virus (AAV) that exhibit altered capsid properties, e.g., reduced binding to neutralizing antibodies in serum and/or altered heparin binding and/or altered infectivity of particular cell types. The present invention further provides libraries of mutant AAV comprising one or more mutations in a capsid gene. The present invention further provides methods of generating the mutant AAV and mutant AAV libraries, and compositions comprising the mutant AAV. The present invention further provides recombinant AAV (rAAV) virions that comprise a mutant capsid protein. The present invention further provides nucleic acids comprising nucleotide sequences that encode mutant capsid proteins, and host cells comprising the nucleic acids. The present invention further provides methods of delivering a gene product to an individual, the methods generally involving administering an effective amount of a subject rAAV virion to an individual in need thereof.
摘要翻译：本发明提供了表现出改变的衣壳特性（例如与血清中的中和抗体的结合减少和/或改变的肝素结合和/或特定细胞类型的感染性改变）的突变腺伴随病毒（AAV）。本发明进一步提供了在衣壳基因中包含一个或多个突变的突变AAV的文库。本发明进一步提供了产生突变AAV和突变AAV文库的方法，以及包含突变AAV的组合物。本发明进一步提供了包含突变体衣壳蛋白的重组AAV（rAAV）病毒粒子。本发明进一步提供了包含编码突变体衣壳蛋白的核苷酸序列的核酸，以及包含该核酸的宿主细胞。本发明进一步提供了将基因产物递送至个体的方法，所述方法通常包括将有效量的受试者rAAV病毒体给予有需要的个体。

2. 发明授权

EP1660678B1 MUTANT ADENO-ASSOCIATED VIRUS VIRIONS AND METHODS OF USE THEREOF 有权转让
标题翻译：突变体腺相关VIRUSVIRIONEN及其使用方法
公开(公告)号：EP1660678B1
公开(公告)日：2011-10-26
申请号：EP04777352.8
申请日：2004-06-29
申请人： The Regents of The University of California , Integrative Gene Therapeutics
发明人： SCHAFFER, David, V. , KASPAR, Brian , MAHESHRI, Narendra
IPC分类号： C12Q1/68 , C12Q1/70 , C12N7/00 , C12N7/01 , C12N7/02 , C12N15/00 , C12N15/09 , C12N15/63 , C12N15/70 , C12N15/74 , C07H21/04
CPC分类号： C07K14/005 , C12N15/86 , C12N2750/14122 , C12N2750/14143
摘要： The present invention provides mutant adeno-associated virus (AAV) that exhibit altered capsid properties, e.g., reduced binding to neutralizing antibodies in serum and/or altered heparin binding and/or altered infectivity of particular cell types. The present invention further provides libraries of mutant AAV comprising one or more mutations in a capsid gene. The present invention further provides methods of generating the mutant AAV and mutant AAV libraries, and compositions comprising the mutant AAV. The present invention further provides recombinant AAV (rAAV) virions that comprise a mutant capsid protein. The present invention further provides nucleic acids comprising nucleotide sequences that encode mutant capsid proteins, and host cells comprising the nucleic acids. The present invention further provides methods of delivering a gene product to an individual, the methods generally involving administering an effective amount of a subject rAAV virion to an individual in need thereof.

3. 发明公开

EP1660678A2 MUTANT ADENO-ASSOCIATED VIRUS VIRIONS AND METHODS OF USE THEREOF 有权转让
标题翻译：突变体腺相关VIRUSVIRIONEN及其使用方法
公开(公告)号：EP1660678A2
公开(公告)日：2006-05-31
申请号：EP04777352.8
申请日：2004-06-29
申请人： The Regents of the University of California
发明人： SCHAFFER, David, V. , KASPAR, Brian , MAHESHRI, Narendra
IPC分类号： C12Q1/68 , C12Q1/70 , C12N7/00 , C12N7/01 , C12N7/02 , C12N15/00 , C12N15/09 , C12N15/63 , C12N15/70 , C12N15/74 , C07H21/04
CPC分类号： C07K14/005 , C12N15/86 , C12N2750/14122 , C12N2750/14143
摘要： The present invention provides mutant adeno-associated virus (AAV) that exhibit altered capsid properties, e.g., reduced binding to neutralizing antibodies in serum and/or altered heparin binding and/or altered infectivity of particular cell types. The present invention further provides libraries of mutant AAV comprising one or more mutations in a capsid gene. The present invention further provides methods of generating the mutant AAV and mutant AAV libraries, and compositions comprising the mutant AAV. The present invention further provides recombinant AAV (rAAV) virions that comprise a mutant capsid protein. The present invention further provides nucleic acids comprising nucleotide sequences that encode mutant capsid proteins, and host cells comprising the nucleic acids. The present invention further provides methods of delivering a gene product to an individual, the methods generally involving administering an effective amount of a subject rAAV virion to an individual in need thereof.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式